Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support: A Pilot Study.

Bonios MJ, Koliopoulou A, Wever-Pinzon O, Taleb I, Stehlik J, Xu W, Wever-Pinzon J, Catino A, Kfoury AG, Horne BD, Nativi-Nicolau J, Adamopoulos SN, Fang JC, Selzman CH, Bax JJ, Drakos SG.

Circ Cardiovasc Imaging. 2018 Apr;11(4):e007117. doi: 10.1161/CIRCIMAGING.117.007117.

PMID:
29653930
2.

AMPK promotes survival of c-Myc-positive melanoma cells by suppressing oxidative stress.

Kfoury A, Armaro M, Collodet C, Sordet-Dessimoz J, Giner MP, Christen S, Moco S, Leleu M, de Leval L, Koch U, Trumpp A, Sakamoto K, Beermann F, Radtke F.

EMBO J. 2018 Mar 1;37(5). pii: e97673. doi: 10.15252/embj.201797673. Epub 2018 Feb 12.

PMID:
29440228
3.

Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support.

Catino AB, Ferrin P, Wever-Pinzon J, Horne BD, Wever-Pinzon O, Kfoury AG, McCreath L, Diakos NA, McKellar S, Koliopoulou A, Bonios MJ, Al-Sarie M, Taleb I, Dranow E, Fang JC, Drakos SG.

Eur J Heart Fail. 2018 Jan;20(1):164-174. doi: 10.1002/ejhf.1018. Epub 2017 Nov 1.

PMID:
29094485
4.

Implementation of Real-Time Assessment of Patient-Reported Outcomes in a Heart Failure Clinic: A Feasibility Study.

Stehlik J, Rodriguez-Correa C, Spertus JA, Biber J, Nativi-Nicolau J, Zickmund S, Steinberg BA, Peritz DC, Walker A, Hess J, Drakos SG, Kfoury AG, Fang JC, Selzman CH, Hess R.

J Card Fail. 2017 Nov;23(11):813-816. doi: 10.1016/j.cardfail.2017.09.009. Epub 2017 Oct 2.

PMID:
28982635
5.

Regional myocardial structural characteristics in ischemic and non-ischemic cardiomyopathy: Left ventricle versus right and apex versus base.

Diakos NA, Passi S, Taleb I, Kfoury AG, Drakos SG.

J Heart Lung Transplant. 2018 Jan;37(1):166-169. doi: 10.1016/j.healun.2017.07.027. Epub 2017 Jul 29. No abstract available.

PMID:
28890255
6.

Clinical Decision Support to Efficiently Identify Patients Eligible for Advanced Heart Failure Therapies.

Evans RS, Kfoury AG, Horne BD, Lloyd JF, Benuzillo J, Rasmusson KD, Roberts C, Lappé DL.

J Card Fail. 2017 Oct;23(10):719-726. doi: 10.1016/j.cardfail.2017.08.449. Epub 2017 Aug 16.

PMID:
28821391
7.

Health characteristics of heart transplant recipients surviving into their 80s.

Tabachnick DR, Bowen ME, Stehlik J, Kfoury AG, Caine WT, Selzman CH, McKellar SH; Utah Cardiac Transplant Program (UCTP).

J Surg Res. 2017 Aug;216:99-102. doi: 10.1016/j.jss.2017.04.021. Epub 2017 May 6.

PMID:
28807220
8.

Favorable Effects on Pulmonary Vascular Hemodynamics with Continuous-Flow Left Ventricular Assist Devices Are Sustained 5 Years After Heart Transplantation.

Saidi A, Selzman CH, Ahmadjee A, Al-Sarie M, Snow GL, Wever-Pinzon O, Alharethi R, Reid B, Stehlik J, Kfoury AG, Bader F.

ASAIO J. 2018 Jan/Feb;64(1):38-42. doi: 10.1097/MAT.0000000000000614.

PMID:
28661912
9.

Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning.

Diakos NA, Navankasattusas S, Abel ED, Rutter J, McCreath L, Ferrin P, McKellar SH, Miller DV, Park SY, Richardson RS, Deberardinis R, Cox JE, Kfoury AG, Selzman CH, Stehlik J, Fang JC, Li DY, Drakos SG.

JACC Basic Transl Sci. 2016 Oct;1(6):432-444. doi: 10.1016/j.jacbts.2016.06.009. Epub 2016 Oct 31.

10.

Contributions of local and regional anthropogenic sources of metals in PM2.5 at an urban site in northern France.

Ledoux F, Kfoury A, Delmaire G, Roussel G, El Zein A, Courcot D.

Chemosphere. 2017 Aug;181:713-724. doi: 10.1016/j.chemosphere.2017.04.128. Epub 2017 Apr 27.

PMID:
28477528
11.

On the Road to Full Cardiac Recovery With Mechanical Unloading: Are We There Yet?

Kfoury AG.

J Am Coll Cardiol. 2017 Apr 18;69(15):1934-1936. doi: 10.1016/j.jacc.2017.02.032. No abstract available.

12.

Early inpatient calculation of laboratory-based 30-day readmission risk scores empowers clinical risk modification during index hospitalization.

Horne BD, Budge D, Masica AL, Savitz LA, Benuzillo J, Cantu G, Bradshaw A, McCubrey RO, Bair TL, Roberts CA, Rasmusson KD, Alharethi R, Kfoury AG, James BC, Lappé DL.

Am Heart J. 2017 Mar;185:101-109. doi: 10.1016/j.ahj.2016.12.010. Epub 2016 Dec 29.

PMID:
28267463
13.

Antibody-mediated rejection in the cardiac allograft: diagnosis, treatment and future considerations.

Hammond ME, Kfoury AG.

Curr Opin Cardiol. 2017 Feb 15. doi: 10.1097/HCO.0000000000000390. [Epub ahead of print]

PMID:
28212151
14.

Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.

Wever-Pinzon J, Selzman CH, Stoddard G, Wever-Pinzon O, Catino A, Kfoury AG, Diakos NA, Reid BB, McKellar S, Bonios M, Koliopoulou A, Budge D, Kelkhoff A, Stehlik J, Fang JC, Drakos SG.

J Am Coll Cardiol. 2016 Oct 18;68(16):1741-1752. doi: 10.1016/j.jacc.2016.07.756.

15.

Cardiac Recovery During Long-Term Left Ventricular Assist Device Support.

Wever-Pinzon O, Drakos SG, McKellar SH, Horne BD, Caine WT, Kfoury AG, Li DY, Fang JC, Stehlik J, Selzman CH.

J Am Coll Cardiol. 2016 Oct 4;68(14):1540-53. doi: 10.1016/j.jacc.2016.07.743.

16.

Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.

Wever-Pinzon O, Edwards LB, Taylor DO, Kfoury AG, Drakos SG, Selzman CH, Fang JC, Lund LH, Stehlik J.

J Heart Lung Transplant. 2017 Apr;36(4):407-417. doi: 10.1016/j.healun.2016.08.008. Epub 2016 Aug 20.

PMID:
27686602
17.

Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant.

Ko BS, Drakos S, Kfoury AG, Hurst D, Stoddard GJ, Willis CA, Delgado JC, Hammond EH, Gilbert EM, Alharethi R, Revelo MP, Nativi-Nicolau J, Reid BB, McKellar SH, Wever-Pinzon O, Miller DV, Eckels DD, Fang JC, Selzman CH, Stehlik J; Utah Transplant Affiliated Hospitals (U.T.A.H.) Cardiac Transplant Program.

J Heart Lung Transplant. 2016 Aug;35(8):1024-30. doi: 10.1016/j.healun.2016.05.001. Epub 2016 May 6.

PMID:
27316382
18.

Myocardial Structural and Functional Response After Long-Term Mechanical Unloading With Continuous Flow Left Ventricular Assist Device: Axial Versus Centrifugal Flow.

Al-Sarie M, Rauf A, Kfoury AG, Catino A, Wever-Pinzon J, Bonios M, Horne BD, Diakos NA, Wever-Pinzon O, McKellar SH, Kelkhoff A, McCreath L, Fang J, Stehlik J, Selzman CH, Drakos SG.

JACC Heart Fail. 2016 Jul;4(7):570-576. doi: 10.1016/j.jchf.2016.02.015. Epub 2016 May 11.

19.

B cells in transplantation.

Dijke EI, Platt JL, Blair P, Clatworthy MR, Patel JK, Kfoury AG, Cascalho M.

J Heart Lung Transplant. 2016 Jun;35(6):704-10. doi: 10.1016/j.healun.2016.01.1232. Epub 2016 Feb 12.

20.

ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.

Hammond MEH, Revelo MP, Miller DV, Snow GL, Budge D, Stehlik J, Molina KM, Selzman CH, Drakos SG, Rami A A, Nativi-Nicolau JN, Reid BB, Kfoury AG.

J Heart Lung Transplant. 2016 Mar;35(3):320-325. doi: 10.1016/j.healun.2015.10.035. Epub 2015 Oct 30.

PMID:
26970471
21.

PM2.5 source apportionment in a French urban coastal site under steelworks emission influences using constrained non-negative matrix factorization receptor model.

Kfoury A, Ledoux F, Roche C, Delmaire G, Roussel G, Courcot D.

J Environ Sci (China). 2016 Feb;40:114-28. doi: 10.1016/j.jes.2015.10.025. Epub 2016 Jan 12.

PMID:
26969551
22.

Reasons for, and outcomes of patients who were referred for a ventricular assist device but were declined: the recent era forgotten ones.

Johnson AK, McCandless SP, Alharethi R, Caine WT, Budge D, Wright GA, Rauf A, Miller A, Stoker S, Smith H, Afshar K, Reid BB, Rasmusson BY, Kfoury AG.

Clin Transplant. 2016 Mar;30(3):195-201. doi: 10.1111/ctr.12670. Epub 2016 Feb 6.

PMID:
26589376
23.

Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations.

Kfoury AG, Miller DV, Snow GL, Afshar K, Stehlik J, Drakos SG, Budge D, Fang JC, Revelo MP, Alharethi RA, Gilbert EM, Caine WT, McKellar S, Molina KM, Hammond MEH.

J Heart Lung Transplant. 2016 Mar;35(3):335-341. doi: 10.1016/j.healun.2015.10.016. Epub 2015 Oct 23.

PMID:
26586489
24.

The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children.

Ware AL, Malmberg E, Delgado JC, Hammond ME, Miller DV, Stehlik J, Kfoury A, Revelo MP, Eckhauser A, Everitt MD.

J Heart Lung Transplant. 2016 Feb;35(2):179-85. doi: 10.1016/j.healun.2015.10.006. Epub 2015 Oct 8.

PMID:
26520246
25.

Combined use of TandemHeart percutaneous ventricular assist device and Stereotaxis magnetic navigation during cardiac ablation procedure.

Miller AC, Evans AC, Revenaugh J, Weiss JP, Reid BB, Kfoury AG.

HeartRhythm Case Rep. 2015 Sep 30;2(1):14-16. doi: 10.1016/j.hrcr.2015.08.006. eCollection 2016 Jan. No abstract available.

26.

Elevated resting heart rate in heart transplant recipients: innocent bystander or adverse prognostic indicator?

Wachter SB, McCandless SP, Gilbert EM, Stoddard GJ, Kfoury AG, Reid BB, McKellar SH, Nativi-Nicolau J, Saidi A, Barney J, McCreath L, Koliopoulou A, Wright SE, Fang JC, Stehlik J, Selzman CH, Drakos SG.

Clin Transplant. 2015 Sep;29(9):829-34. doi: 10.1111/ctr.12587. Epub 2015 Jul 27.

PMID:
26171948
27.

Ultraviolet Radiation Affects Thoratec HeartMate II Driveline Mechanical Properties: A Pilot Experiment.

Evans AC, Wright GA, McCandless SP, Stoker S, Miller D, Reid BB, Horne BD, Afshar K, Kfoury AG.

ASAIO J. 2015 Nov-Dec;61(6):731-3. doi: 10.1097/MAT.0000000000000260.

PMID:
26102175
28.

Reply: does size matter? In search of a physiological definition of myocardial atrophy.

Diakos NA, Selzman CH, Stehlik J, Sachse FB, Kfoury AG, Koliopoulou A, McKellar S, Fang JC, Li DY, Drakos SG.

J Am Coll Cardiol. 2015 May 19;65(19):2156-7. doi: 10.1016/j.jacc.2015.02.064. No abstract available.

29.

Gene expression profiling to study racial differences after heart transplantation.

Khush KK, Pham MX, Teuteberg JJ, Kfoury AG, Deng MC, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Hiller D, Yee J, Valantine HA.

J Heart Lung Transplant. 2015 Jul;34(7):970-7. doi: 10.1016/j.healun.2015.01.987. Epub 2015 Feb 7.

30.

Marital status and survival in left ventricular assist device patient populations.

Wright GA, Rauf A, Stoker S, Alharethi R, Kfoury AG.

J Heart Lung Transplant. 2015 Apr;34(4):619-21. doi: 10.1016/j.healun.2014.11.016. Epub 2014 Nov 15. No abstract available.

PMID:
25612862
31.

Lactic acidosis after cardiac transplantation: foe or common innocent bystander?

Nixon JL, Kfoury AG, McCubrey R, Brunisholz K, Bair T, Balling KD, Budge D, Doty J, Rasmusson B, Reid B, Smith H, Thomsen G, Goddard M, Alharethi R.

Transplantation. 2015 Jun;99(6):1216-9. doi: 10.1097/TP.0000000000000508.

PMID:
25539461
32.

Comparing velour versus silicone interfaces at the driveline exit site of HeartMate II devices: infection rates, histopathology, and ultrastructural aspects.

McCandless SP, Ledford ID, Mason NO, Alharethi R, Rasmusson BY, Budge D, Stoker SL, Clayson SE, Doty JR, Thomsen GE, Caine WT, Kfoury AG, Reid BB, Miller DV.

Cardiovasc Pathol. 2015 Mar-Apr;24(2):71-5. doi: 10.1016/j.carpath.2014.07.011. Epub 2014 Oct 22.

PMID:
25483742
33.

Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery.

Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Wever-Pinzon O, Catino A, Alharethi R, Reid BB, Miller DV, Salama M, Zaitsev AV, Shibayama J, Li H, Fang JC, Li DY, Drakos SG.

J Am Coll Cardiol. 2014 Oct 14;64(15):1602-12. doi: 10.1016/j.jacc.2014.05.073.

34.

Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation.

Abdullah OM, Drakos SG, Diakos NA, Wever-Pinzon O, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Brunisholz K, Verma DR, Myrick C, Sachse FB, Li DY, Hsu EW.

NMR Biomed. 2014 Nov;27(11):1378-86. doi: 10.1002/nbm.3200. Epub 2014 Sep 9.

35.

Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials.

Wever-Pinzon O, Romero J, Kelesidis I, Wever-Pinzon J, Manrique C, Budge D, Drakos SG, Piña IL, Kfoury AG, Garcia MJ, Stehlik J.

J Am Coll Cardiol. 2014 May 20;63(19):1992-2004. doi: 10.1016/j.jacc.2014.01.071. Epub 2014 Mar 26.

PMID:
24681148
36.

Utility of gene expression profiling score variability to predict clinical events in heart transplant recipients.

Deng MC, Elashoff B, Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Cappola TP, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Bogaev RC, Shahzad K, Hiller D, Yee J, Valantine HA; IMAGE Study Group.

Transplantation. 2014 Mar 27;97(6):708-14. doi: 10.1097/01.TP.0000443897.29951.cf.

37.

Survival based on patient selection for heart transplant in adults with congenital heart disease: a multi-institutional study.

Boucek D, Yetman AT, Yeung E, Miyamoto SD, Stehlik J, Kfoury AG, Kaza AK, Weng C, Everitt MD.

Int J Cardiol. 2014;172(1):e89-90. doi: 10.1016/j.ijcard.2013.12.133. Epub 2014 Jan 4. No abstract available.

PMID:
24433616
38.

Dual function of MyD88 in inflammation and oncogenesis: implications for therapeutic intervention.

Kfoury A, Virard F, Renno T, Coste I.

Curr Opin Oncol. 2014 Jan;26(1):86-91. doi: 10.1097/CCO.0000000000000037. Review.

PMID:
24285099
39.

Reply: left ventricular assist devices in chronic heart failure: more questions than answers?

Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Stehlik J, Drakos SG.

J Am Coll Cardiol. 2013 Dec 10;62(23):2257-8. doi: 10.1016/j.jacc.2013.08.713. Epub 2013 Sep 4. No abstract available.

40.

The detection and role of circulating antibodies in rejection.

Eckels DD, Stehlik J, Kfoury AG.

Curr Opin Organ Transplant. 2013 Oct;18(5):589-94. doi: 10.1097/MOT.0b013e328364fe3d. Review.

PMID:
23995369
41.

Repeated measurement of the intermountain risk score enhances prognostication for mortality.

Horne BD, Lappé DL, Muhlestein JB, May HT, Ronnow BS, Brunisholz KD, Kfoury AG, Bunch TJ, Alharethi R, Budge D, Whisenant BK, Bair TL, Jensen KR, Anderson JL.

PLoS One. 2013 Jul 17;8(7):e69160. doi: 10.1371/journal.pone.0069160. Print 2013.

42.

MyD88 in DNA repair and cancer cell resistance to genotoxic drugs.

Kfoury A, Le Corf K, El Sabeh R, Journeaux A, Badran B, Hussein N, Lebecque S, Manié S, Renno T, Coste I.

J Natl Cancer Inst. 2013 Jul 3;105(13):937-46. doi: 10.1093/jnci/djt120. Epub 2013 Jun 13.

43.

Interleukin receptor family member ST2 concentrations in patients following heart transplantation.

Januzzi JL, Horne BD, Moore SA, Galenko O, Snow GL, Brunisholz KD, Muhlestein JB, Alharethi R, Carlquist JF, Budge D, Rasmussen K, Kfoury AG.

Biomarkers. 2013 May;18(3):250-6. doi: 10.3109/1354750X.2013.773081. Epub 2013 Apr 5.

PMID:
23557127
44.

Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery.

Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury AG; UCAR (Utah Cardiac Recovery Program) Investigators.

J Am Coll Cardiol. 2013 May 14;61(19):1985-94. doi: 10.1016/j.jacc.2013.01.072. Epub 2013 Mar 14.

45.

Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II.

Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader F.

Circ Heart Fail. 2013 May;6(3):517-26. doi: 10.1161/CIRCHEARTFAILURE.112.000206. Epub 2013 Mar 11.

46.

Chemical profile identification of fugitive and confined particle emissions from an integrated iron and steelmaking plant.

Hleis D, Fernández-Olmo I, Ledoux F, Kfoury A, Courcot L, Desmonts T, Courcot D.

J Hazard Mater. 2013 Apr 15;250-251:246-55. doi: 10.1016/j.jhazmat.2013.01.080. Epub 2013 Feb 8.

PMID:
23454464
47.

Electromagnetic interference of automatic implantable cardioverter defibrillator and HeartWare left ventricular assist device.

Labedi MR, Alharethi R, Kfoury AG, Budge D, Bruce R, Rasmusson B, Bunch TJ.

ASAIO J. 2013 Mar-Apr;59(2):136-9. doi: 10.1097/MAT.0b013e318285fe93.

PMID:
23438775
48.

Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial.

Eisen HJ, Kobashigawa J, Starling RC, Pauly DF, Kfoury A, Ross H, Wang SS, Cantin B, Van Bakel A, Ewald G, Hirt S, Lehmkuhl H, Keogh A, Rinaldi M, Potena L, Zuckermann A, Dong G, Cornu-Artis C, Lopez P.

Am J Transplant. 2013 May;13(5):1203-16. doi: 10.1111/ajt.12181. Epub 2013 Feb 22.

49.

p58(IPK)-mediated attenuation of the proapoptotic PERK-CHOP pathway allows malignant progression upon low glucose.

Huber AL, Lebeau J, Guillaumot P, Pétrilli V, Malek M, Chilloux J, Fauvet F, Payen L, Kfoury A, Renno T, Chevet E, Manié SN.

Mol Cell. 2013 Mar 28;49(6):1049-59. doi: 10.1016/j.molcel.2013.01.009. Epub 2013 Feb 7.

50.

Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?

Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J.

Circulation. 2013 Jan 29;127(4):452-62. doi: 10.1161/CIRCULATIONAHA.112.100123. Epub 2012 Dec 27.

Supplemental Content

Loading ...
Support Center